Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
38 Patents
#6 in Davis, CA
#2,133 in California
#9,027 in US
#17,844 in the World
Novozymes Biotech, Inc
Forward Citations = 235
43 inventors:
Davis, CA, United States of America
Novozymes Biotech, Inc
% Expired Patents = 23.7
Forward Citations = 235
Loading Chart...
Loading Chart...
43 inventors (with patents filed for the assignee):
Michael W Rey (16 out of 63 patents)
Randy M Berka (12 out of 63 patents)
Debbie Sue Yaver (10 out of 81 patents)
4. Elizabeth J Golightly (8 out of 24 patents)
5. Kimberly M Brown (7 out of 67 patents)
6. Feng Xu (4 out of 50 patents)
7. Alexander Blinkovsky (4 out of 17 patents)
8. Jeffrey R Shuster (3 out of 23 patents)
9. John C Royer (3 out of 17 patents)
10. Alan V Klotz (3 out of 17 patents)
11. Stephen H Brown (3 out of 20 patents)
12. Tony S Byun (3 out of 10 patents)
13. Howard Brody (2 out of 17 patents)
14. Sakari Kauppinen (2 out of 26 patents)
15. Wendy T Yoder (2 out of 4 patents)
Core Competencies:
Coronamycins
Carboxypeptidases
Gene Expression
Polypeptides
Filamentous Fungi
Biofilm Elimination
Lactonohydrolase
Lipase Activity
Fungal Cell Promoters
Translational Initiator
Hemoprotein Production
Pectate Lyases
38 patents:
6. 6893839 - Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells (2005-05-17),
7. 6800467 - Polypeptides having aminopeptidase activity and nucleic acids encoding same (2004-10-05),
10. 6756220 - Polypeptides having lactonohydrolase activity and nucleic acids encoding same (2004-06-29),
Company Overview
Novozymes Biotech, Inc. is a leading biotechnology company based in Davis, California, specializing in the development and production of enzymes and microorganisms for various industries. The company focuses on innovative solutions that enhance sustainability and efficiency in agriculture, bioenergy, and industrial applications. With a strong commitment to research and development, Novozymes leverages advanced biotechnology to create products that improve performance and reduce environmental impact, positioning itself as a key player in the global biotech landscape.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novozymes Biotech, Inc. Retrieved from https://idiyas.com/company/novozymes-biotech
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]